Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 1.

Table. 1.

Patients’ demographics, preoperative investigation results, pathology findings, and operative characteristics (n = 288)

Characteristic Value
Age (yr) 63.5 ± 10.3
Sex (male : female) 166 (57.6) : 122 (42.4)
ASA
1 46 (16.0)
2 183 (63.5)
3 59 (20.5)
Hemoglobin (g/dL) 12.2 ± 1.6
Platelet (× 109/L) 262.0 ± 91.9
White cell count (× 109/L) 6.9 ± 2.6
International normalized ratio 1.01 ± 0.08
Creatinine (mmol/L) 75.8 ± 22.1
Albumin (g/L) 36.3 ± 5.9
Bilirubin (µmol/L) 59.7 ± 93.6
Alkaline phosphatase (IU/L) 208.0 ± 201.8
Histological diagnosis
Benign 54 (18.8)
Malignant 234 (81.2)
Carcinoma of pancreas 92 (31.9)
Carcinoma of ampulla 62 (21.5)
Cholangiocarcinoma 36 (12.5)
Intraductal papillary mucinous tumor 22 (7.6)
Carcinoma of duodenum 12 (4.2)
Neuroendocrine tumor of pancreas 12 (4.2)
Cystic neoplasm of pancreas 6 (2.1)
Gastrointestinal stromal tumor 6 (2.1)
Others 40 (13.9)
Pancreas texture
Soft 194 (67.4)
Hard 94 (32.6)
Operative approach
Open 280 (97.2)
Laparoscopic/robotic to open 4 (1.4)
Robotic 4 (1.4)
Type of operation
Standard Whipple 112 (38.9)
Pylorus preserving pancreaticoduodenectomy 176 (61.1)
Vascular resection/reconstruction 14 (4.9)
Concomitant procedures 12 (4.2)
Pancreatic duct size (mm) 4.0 ± 2.2
Use of pancreatic internal stent 39 (13.5)
Prophylactic Sandostatin 274 (95.1)

Values are presented as mean ± standard deviation or number (%).

ASA: American Society of Anesthesiologists.

Ann Hepatobiliary Pancreat Surg 2022;26:84-90 https://doi.org/10.14701/ahbps.21-054
© 2021 Ann Hepatobiliary Pancreat Surg